Cellular Matrix combines the hydration effect of hyaluronic acid (ha) biopolymer with the stimulation properties of the growth factors in Autologous Platelet Rich Plasma. While Hyaluronic Acid acts as a temporary dermal substitute, A-PRP stimulates the surrounding cells.
After injection, the three-dimensional Cellular Matrix scaffold is promptly colonized by fibroblasts, which produce extracellular matrix components and promote the ordered reconstruction of dermal tissue.
Cellular Matrix Product Characteristics:
PRP & HA All-In-One
CellularMatrix is a Class III Medical Device certified by SNCH (N°0499). Patented by Regen Lab SA.
International Publication Number: WO2011/110948. CellularMatrix is CE Marked and is only available trough authorized distributors. The Product has not yet been approved or cleared for marketing by the United States Food & Drug Administration.